Insider screener

Period: 12 months Role: Other officers × + Add filter Clear all
Saved screens

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

22,712 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

22,712 decisions over 12 months Remove this filter
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

22,712 decisions over 12 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

22,712 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
22,712 decisions over 12 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
22,712 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

22,712 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
2 Mar 2026
Tim Watkins CMO & Head of Development
Sold on a plan
$54.22K 3,611 at 15.02
100%
Sold half or more
2 Mar 2026
Ajay Ayyappan EVP & Gen Counsel/Corp. Sec'y.
Sold on a plan
$51.02K 1,679 at 30.39
3.0%
Planned (10b5-1)
2 Mar 2026
Dominic Smethurst Chief Medical Officer
Sold at will
$50.60K 6,097 at 8.30
6.4%
Not planned
2 Mar 2026
Joshua Peck Vice President
Bought
$49.96K 2,840 at 17.59
947%
First buy on file
2 Mar 2026
Nicholas Adam Jendusa Principal Accounting Officer
Sold at will
$48.55K 190 at 255.51
38.3%
Not planned
2 Mar 2026
Michael G. Nassy Sr EVP, Chief Credit Officer
Sold at will
$48.24K 3,100 at 15.56
5.3%
Not planned
2 Mar 2026
Stuart Poulton EVP, Chief Development Officer
Sold at will
$48.00K 5,101 at 9.41
5.1%
Not planned
2 Mar 2026
Reshma Rangwala EVP & Chief Medical Officer
Sold at will
$47.67K 5,066 at 9.41
8.2%
Not planned
2 Mar 2026
Regan Patrick O'Dea VP, General Counsel
Bought
$45.10K 578 at 78.04
3.9%
First buy on file
2 Mar 2026
Uri Weinberg Chf Medical and Innovation Ofr
Sold at will
$43.61K 3,272 at 13.33
1.4%
Not planned
2 Mar 2026
Sohanya Roshan Cheng EVP & Chief Commercial Officer
Sold at will
$43.32K 4,604 at 9.41
4.1%
Not planned
2 Mar 2026
Seana Carson EVP, General Counsel
Sold on a plan
$39.63K 6,856 at 5.78
0.9%
Planned (10b5-1)
2 Mar 2026
Kellie Teal-Guess Chief Human Resources Officer
Sold on a plan
$38.49K 21,266 at 1.81
2.0%
Planned (10b5-1)
2 Mar 2026
Todd C. Skinner President, International
Sold on a plan
$38.32K 500 at 76.64
0.9%
Planned (10b5-1)
2 Mar 2026
Allison Swartz EVP, GC
Sold on a plan
$37.98K 2,199 at 17.27
2.2%
Planned (10b5-1)
2 Mar 2026
Jonathan L. Caldwell Chief People Officer
Sold on a plan
$37.35K 983 at 38.00
3.6%
Planned (10b5-1)
2 Mar 2026
Theodore Alan Huizenga SVP, Chief Accounting Officer
Sold at will
$37.21K 1,632 at 22.80
3.2%
Not planned
2 Mar 2026
Sarah Elizabeth Schubach Chief Accounting Officer
Sold on a plan
$35.04K 1,415 at 24.76
1.6%
Planned (10b5-1)
2 Mar 2026
Ashley Kavanaugh VP, Principal Accting Officer · indirect
Sold at will
$35.01K 836 at 41.88
48.5%
Not planned
2 Mar 2026
Michael Mano EVP, CLO&Secretary
Sold at will
$33.18K 3,526 at 9.41
3.6%
Not planned
2 Mar 2026
Russell Schundler General Counsel
Sold on a plan
$32.81K 1,073 at 30.58
0.2%
Planned (10b5-1)
2 Mar 2026
Dean Richard Artis EVP & Chief Scientific Officer
Sold at will
$32.00K 5,894 at 5.43
3.2%
Not planned
2 Mar 2026
Jamie Dananberg Chief Medical Officer
Sold at will
$31.60K 5,820 at 5.43
4.5%
Not planned
2 Mar 2026
Robert Allen John Chief Revenue Officer
Sold on a plan
$31.33K 3,964 at 7.90
4.4%
Planned (10b5-1)
2 Mar 2026
Christopher Mutz Head of Rare Disease
Sold on a plan
$30.86K 417 at 74.00
0.4%
Planned (10b5-1)
2 Mar 2026
Elizabeth C. Cushman EVP, GC and Secretary
Sold at will
$30.40K 263 at 115.58
0.7%
Not planned
2 Mar 2026
Ted Yednock EVP & Chief Innovation Officer
Sold at will
$30.17K 5,566 at 5.42
3.5%
Not planned
2 Mar 2026
Michael Olsen General Counsel and CCRO
Sold on a plan
$28.00K 20,000 at 1.40
1.6%
Planned (10b5-1)
2 Mar 2026
Cory Vieira Chief Accounting Officer
Sold at will
$27.19K 2,490 at 10.92
14.1%
Not planned
2 Mar 2026
Karen Akinsanya See Remarks
Sold on a plan
$26.45K 2,206 at 11.99
3.0%
Planned (10b5-1)
2 Mar 2026
Rohan Malhotra See Remarks
Bought
$26.15K 19,085 at 1.37
2.3%
Largest buy in 3 yrs
2 Mar 2026
Craig Saldanha Chief Product Officer
Sold on a plan
$26.14K 1,200 at 21.78
0.5%
Planned (10b5-1)
2 Mar 2026
Scott Moomaw Chief Commercial Officer
Sold on a plan
$25.29K 827 at 30.58
0.4%
Planned (10b5-1)
2 Mar 2026
Amy Horton VP, Chief Accounting Officer
Sold at will
$24.37K 641 at 38.02
0.5%
Not planned
2 Mar 2026
Michael Overdorf EVP & Chief Business Officer
Sold at will
$23.52K 4,339 at 5.42
2.3%
Not planned
2 Mar 2026
Monica Raines EVP, CCO and Quality Officer
Sold on a plan
$22.88K 224 at 102.15
1.6%
Planned (10b5-1)
2 Mar 2026
Prerna Sachdeva Chief Accounting Officer
Sold at will
$22.85K 1,352 at 16.90
2.1%
Not planned
2 Mar 2026
Jason Adair Chief Business Officer
Sold on a plan
$21.07K 689 at 30.58
0.3%
Planned (10b5-1)
2 Mar 2026
Richard Francis Crum EVP, Chief Prod & Tech Officer
Sold at will
$20.29K 6,262 at 3.24
1.8%
Not planned
2 Mar 2026
Nicolas Karmelek EVP and CRO
Bought
$20.26K 1,090 at 18.59
20.2%
+20% of stake
2 Mar 2026
Robert J Mears Chief Technology Officer
Sold on a plan 4×
$19.70K 3,979 at 4.95
2.3%
Planned (10b5-1)
2 Mar 2026
Susan Garcia GC & Chief Compliance Officer
Sold at will
$19.30K 5,956 at 3.24
3.7%
Not planned
2 Mar 2026
Phyllis Gotlib President, International
Sold at will
$18.72K 3,573 at 5.24
3.0%
Not planned
2 Mar 2026
Benjamin Machinas Beneski SVP, Chief Technical Officer
Sold at will
$18.54K 7,132 at 2.60
3.4%
Not planned
2 Mar 2026
David Aaron Lehman General Counsel
Sold at will 4×
$17.50K 12,237 at 1.43
4.8%
Not planned
2 Mar 2026
Grace Wong-Sarad Principal Accounting Officer
Sold at will
$17.14K 8,071 at 2.12
6.8%
Not planned
2 Mar 2026
James Basta EVP, General Counsel
Sold at will
$16.69K 1,211 at 13.78
0.8%
Not planned
2 Mar 2026
Walid Abi-Saab Chief Medical Officer
Sold at will
$16.52K 1,660 at 9.95
1.1%
Not planned
2 Mar 2026
Ichiro Aoki President
Sold at will 2×
$16.29K 4,573 at 3.56
4.3%
Not planned
2 Mar 2026
Melanie Antoon EVP, Chief Customer Officer
Sold at will
$15.82K 4,882 at 3.24
1.7%
Not planned
Showing 15,301–15,350 of 22,712. ← Newer Page 307 of 455 Older →